Workshops & Seminars

  • Home
  • Workshops & Seminars

Planova™ Workshops and Local Seminars

The Planova Workshop is an opportunity for Planova users to share experiences and to learn the best practices of virus filtration. Event chairs and speakers at this annual event are key industry leaders in biotherapeutics, and their presentations cover topics such as tips for process optimization, validations, regulatory requirements and scaling up to commercial manufacturing. Event attendees include experts in the fields of regulation, process development, pathogen safety, quality and manufacturing. Since the first Planova Workshop held in 1998 in Oslo, Norway, this annual event has greatly contributed to raising awareness on viral safety as well as effective use of virus filtration in the manufacturing processes of biotherapeutics.

Planova Local Seminars are similar events tailored to the needs of certain local regions, with additions of presentations covering case studies from global and local companies as well as regulatory updates on viral safety specific to the region.

In this Page, you can explore details of the upcoming events as well as download materials available from past events (login required).

Upcoming Events

Below you can find details of the upcoming events, including registration forms once they are available.

The 3rd Planova™ Seminar in Moscow

Nov 19, 2018
Moscow, Russia

Latest Workshops

Below you can find details of the last five Planova Workshops and download the presentation materials (login required). To find information on other previous Planova Workshops, click Archive.

Latest Seminars

Below you can find details of the last five Local Seminars and download the presentation materials (login required). To find information on other previous Local Seminars, click Archive.

Search Presentations

Here you can search and download (login required) presentation materials from past Planova Workshops, by entering keyword or by using filters for each category.

Keyword

Filter by Protein Type

Filter by Contents

Filter by Products

You need to log in to download the files.

141 Results Found

  1. 10
  2. 20
  3. 30
  4. All
  1. Consistent and Reliable 100% Retrovirus Removal by Planova™ 20N filter: Demonstration of Robust Log Reduction (>6.0) by Co-spiking Study

    Dayue Chen, Virology Group Bioprocess Research and Development, Eli Lilly and Company
    14th Planova™ Workshop
    Nov 9, 2011 to Nov 10, 2011
    Cologne

  2. Virus Inactivation at Low pH: Impact of Buffers, pH Value, Protein Concentration and Temperature on the Inactivation of Retroviruses

    Michael Dieterle, Associate Director Downstream Development, Boehringer Ingelheim GmbH&Co.KG
    14th Planova™ Workshop
    Nov 9, 2011 to Nov 10, 2011
    Cologne

  3. Implementation of Quality by Design to Nanofiltration of Plasma Products

    Monique Ollivier, Director, Process Development-Downstream & Analytics, Cytheris S.A.
    14th Planova™ Workshop
    Nov 9, 2011 to Nov 10, 2011
    Cologne

  4. FULL PLASTICS for a 1000L Disposable Production Line for Generic Antibody Manufacturing

    Peter Rogge, Director, DSP Production, Rentschler Biotechnologie GmbH
    14th Planova™ Workshop
    Nov 9, 2011 to Nov 10, 2011
    Cologne

  5. New Concept of Integrity Test for Planova™ BioEX

    Shinya Sekine, Manager, Technology Development Department, Asahi Kasei Medical Co., Ltd.
    14th Planova™ Workshop
    Nov 9, 2011 to Nov 10, 2011
    Cologne

  6. PDA Technical Report 41: Virus Filtration - History and the Future

    Kurt Brorson, Staff Scientist, CDER, FDA
    15th Planova™ Workshop
    Jun 14, 2012 to Jun 15, 2012
    Boston

  7. The Purity of Virus Spikes: Influences on the Performance of Virus Removal Filters

    Joseph Hughes, Chief Scientist of Virology and Vice President for Service Development, WuXi AppTec, Inc.
    15th Planova™ Workshop
    Jun 14, 2012 to Jun 15, 2012
    Boston

  8. Viral Filtration of Enzyme Therapeutics Using Planova™ 15N and Planova™ 20N filters

    Mei Huei Jang, Senior Scientist, Purification Process Development, Shire Pharmaceuticals
    15th Planova™ Workshop
    Jun 14, 2012 to Jun 15, 2012
    Boston

  9. Integrity Testing of Planova™ BioEX Virus Removal FiltersBioEX Virus Removal Filters

    Shinya Sekine, Manager, Technology Development Department Bioprocess Division, Asahi Kasei Medical Co., Ltd.
    15th Planova™ Workshop
    Jun 14, 2012 to Jun 15, 2012
    Boston

  10. Filtration Robustness of Planova™ BioEX Virus-Removal Filter

    Tomoko Hongo-Hirasaki, Manager, Technology Development Department, Bioprocess Division, Asahi Kasei Medical Co., Ltd.
    15th Planova™ Workshop
    Jun 14, 2012 to Jun 15, 2012
    Boston

  11. Plasma Derivatives and Virus Safety: Relevant Regulations and Guidelines - An Industry Perspective -

    Herbert Dichtelmüller, ViruSafe-Consult
    1st Planova™ Workshop in India
    Jan 31, 2013
    Goa

  12. Planova™ Filters - Virus Removal from Biotherapeutic Products -

    Ravinder Dabas, Manager, Asahi Kasei India Private Limited
    1st Planova™ Workshop in India
    Jan 31, 2013
    Goa

  13. Validation of Virus Filtration Steps - Practical Aspects for Optimization of the Study Design Leading to Optimal Results -

    Olaf Stamm, Senior Specialist, Biopharmaceutical Services, Charles River
    1st Planova™ Workshop in India
    Jan 31, 2013
    Goa

  14. Preparation of Plasma Meeting Requirements for Contract or Domestic Fractionation

    Thierry Burnouf, Director, Human Protein Process Sciences
    1st Planova™ Workshop in India
    Jan 31, 2013
    Goa

  15. Plasma Fractionation - Current Technologies and New Trends -

    Sami Chtourou, Senior Vice President, Innovation and Scientific Affairs, LFB Biotechnologies
    1st Planova™ Workshop in India
    Jan 31, 2013
    Goa

  16. Biotherapeutics and Virus Safety: Relevant Regulations and Guidelines

    Herbert Dichtelmüller, ViruSafe-Consult
    1st Planova™ Workshop in India
    Jan 31, 2013
    Goa

  17. Application of Planova™ Virus Filters in MAb Purification Processes - Impact on Virus Safety and Process Performance -

    Franz Nothelfer, Associate Director, Purification Development, Boehringer Ingelheim Pharma GmbH & Co. KG
    1st Planova™ Workshop in India
    Jan 31, 2013
    Goa

  18. Improvement of MAb Production Cost

    Sami Chtourou, Senior Vice President, Innovation and Scientific Affairs, LFB Biotechnologies
    1st Planova™ Workshop in India
    Jan 31, 2013
    Goa

  19. Ensuring Viral Safety in Recombinant Biotherapeutics

    Sudip Kumar Majumder, Principal Scientist & Head, Downstream Process Development, Intas Biopharmaceuticals Limited
    1st Planova™ Workshop in India
    Jan 31, 2013
    Goa

  20. Investigations of PCV Removal by Planova™ 15N Filters and Planova™ Filters with Pore Size Smaller than 15 nm

    Natascha Hodosi, GLP Study Director, ViruSure
    17th Planova™ Workshop
    Jun 12, 2014 to Jun 13, 2014
    Washington, D.C.

  21. Asahi Gold Particle Test System Development and Implementation Case Study

    Kimo Sanderson, Vice President, Client Services, Asahi Kasei Bioprocess
    17th Planova™ Workshop
    Jun 12, 2014 to Jun 13, 2014
    Washington, D.C.

  22. Use of Porcine Circovirus as a Challenge for Filtration and Other Virus Risk Mitigation Steps

    Kathryn Martin Remington, Principal Scientist, Clearance Services, BioReliance
    17th Planova™ Workshop
    Dec 12, 2014 to Dec 13, 2014
    Washington, D.C.

  23. Virus Filtration and Biotechnology Processes

    Thomas Kreil, Associate Professor of Virology at the Medical University of Vienna and Senior Director, Global Pathogen Safety, Baxter BioScience
    17th Planova™ Workshop
    Jun 12, 2014 to Jun 13, 2014
    Washington, D.C.

  24. Perspective of Plasma-Derived Products in China

    LIU Wenfang, Professor, Institute of Blood Transfusion, Chinese Academy of Medical Sciences/ Peking Union Medical College
    1st Planova™ Workshop in China
    Jan 15, 2015
    Hainan Island

  25. Pathogen Safety of Biological Medicinal Products

    Thomas R.KREIL, Associate Professor of Virology, Senior Director Global Pathogen Safety, BaxterBioScience
    1st Planova™ Workshop in China
    Jan 15, 2015
    Hainan Island